Franklin Resources’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Franklin Resources’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.8M	Buy	169,117 +135,354	+401%	+$18.3M	0.01%	908
2026 Q1	$4.31M	Sell	33,763 -376	-1%	-$46.9K	﹤0.01%	1591
2025 Q4	$4.16M	Buy	34,139 +1,244	+4%	+$143K	﹤0.01%	1490
2025 Q3	$3.3M	Sell	32,895 -13,675	-29%	-$1.23M	﹤0.01%	1593
2025 Q2	$3.86M	Sell	46,570 -8,825	-16%	-$704K	﹤0.01%	1462
2025 Q1	$4.49M	Sell	55,395 -18,534	-25%	-$1.66M	﹤0.01%	1386
2024 Q4	$6.66M	Sell	73,929 -6,060	-8%	-$587K	﹤0.01%	1244
2024 Q3	$7.92M	Buy	79,989 +110	+0.1%	+$10.8K	﹤0.01%	1204
2024 Q2	$7.41M	Sell	79,879 -1,592	-2%	-$143K	﹤0.01%	1181
2024 Q1	$7.73M	Sell	81,471 -8,966	-10%	-$832K	﹤0.01%	1168
2023 Q4	$8.08M	Sell	90,437 -16,561	-15%	-$1.23M	﹤0.01%	980
2023 Q3	$7.81M	Sell	106,998 -7,412	-6%	-$592K	﹤0.01%	958
2023 Q2	$9.52M	Buy	114,410 +6,973	+6%	+$583K	﹤0.01%	935
2023 Q1	$8.19M	Sell	107,437 -10,685	-9%	-$887K	﹤0.01%	970
2022 Q4	$9.8M	Sell	118,122 -3,398	-3%	-$275K	0.01%	947
2022 Q3	$9.64M	Buy	121,520 +29,255	+32%	+$2.47M	0.01%	941
2022 Q2	$6.85M	Buy	92,265 +48,968	+113%	+$3.68M	﹤0.01%	1038
2022 Q1	$3.89M	Buy	43,297 +39,567	+1,061%	+$3.65M	﹤0.01%	1222
2021 Q4	$418K	Sell	3,730 -235	-6%	-$28.3K	﹤0.01%	1974
2021 Q3	$498K	Hold	3,965	–	–	﹤0.01%	1879
2021 Q2	$537K	Buy	3,965 +700	+21%	+$92K	﹤0.01%	1593
2021 Q1	$443K	Buy	3,265 +1,960	+150%	+$293K	﹤0.01%	1627
2020 Q4	$184K	Buy	1,305 +480	+58%	+$61.5K	﹤0.01%	1739
2020 Q3	$92K	Hold	825	–	–	﹤0.01%	1738
2020 Q2	$97K	Buy	+825	New	+$81.3K	﹤0.01%	1566
2019 Q2	–	Sell	-2,245	Closed	-$203K	–	1582
2019 Q1	$203K	Buy	+2,245	New	+$191K	﹤0.01%	1456
2018 Q4	–	Sell	-3,220	Closed	-$309K	–	1533
2018 Q3	$309K	Buy	3,220 +1,000	+45%	+$97K	﹤0.01%	1434
2018 Q2	$211K	Buy	+2,220	New	+$204K	﹤0.01%	1440
2018 Q1	–	Sell	-2,620	Closed	-$222K	–	1551
2017 Q4	$222K	Hold	2,620	–	–	﹤0.01%	1472
2017 Q3	$227K	Buy	+2,620	New	+$210K	﹤0.01%	1444
2015 Q2	–	Sell	-8,400	Closed	-$631K	–	1640
2015 Q1	$631K	Hold	8,400	–	–	﹤0.01%	1427
2014 Q4	$523K	Hold	8,400	–	–	﹤0.01%	1446
2014 Q3	$437K	Hold	8,400	–	–	﹤0.01%	1460
2014 Q2	$431K	Hold	8,400	–	–	﹤0.01%	1451
2014 Q1	$399K	Hold	8,400	–	–	﹤0.01%	1436
2013 Q4	$365K	Hold	8,400	–	–	﹤0.01%	1423
2013 Q3	$362K	Sell	8,400 -450	-5%	-$18.2K	﹤0.01%	1385
2013 Q2	$308K	Buy	+8,850	New	+$311K	﹤0.01%	1384

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Franklin Resources's XBI Position: Q2 2026 in Review

Franklin Resources increased its State Street SPDR S&P Biotech ETF (XBI) stake by 401% in Q2 2026, buying an estimated $18.3M and bringing the position to 169,117 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #908.

Franklin Resources first reported a position in XBI in Q2 2013 and has held it in 38 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Franklin Resources held 169,117 shares of State Street SPDR S&P Biotech ETF worth $26.8M as of Q2 2026.
Franklin Resources bought 135,354 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $18.3M.
State Street SPDR S&P Biotech ETF made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #908 holding.
Franklin Resources first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 38 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.